Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study

Intensive Care Medicine

Volumn 43, Issue 7, 2017, Pages 1013-1020

  Peronnet, Estelle ^a   Venet, Fabienne ^a   Maucort Boulch, Delphine ^b,c,d,e   Friggeri, Arnaud ^a,f,g   Cour, Martin ^a   Argaud, Laurent ^a   Allaouchiche, Bernard ^f   Floccard, Bernard ^d   Aubrun, Frédéric ^d   Rimmelé, Thomas ^a,d   Thiolliere, Fabrice ^f   Piriou, Vincent ^f   Bohé, Julien ^f   Cazalis, Marie Angélique ^a   Barbalat, Véronique ^a   Monneret, Guillaume ^a   Morisset, Stéphane ^a   Textoris, Julien ^a,d   Vallin, Hélène ^a,f   Pachot, Alexandre ^a   Lepape, Alain ^a,f,g   more..

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

^g CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

Biomarkers; CD74; Cross infections; IL10; Immune monitoring; Intensive care unit

Indexed keywords

CD74 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; B LYMPHOCYTE ANTIGEN; BIOLOGICAL MARKER; HLA ANTIGEN CLASS 2; INVARIANT CHAIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INTENSIVE CARE UNIT ACQUIRED INFECTION; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; PNEUMONIA; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEPTIC SHOCK; URINARY CATHETER; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; BLOOD; CLINICAL TRIAL; CROSS INFECTION; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; INCIDENCE; INTENSIVE CARE UNIT; METABOLISM; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BIOMARKERS; CROSS INFECTION; FEMALE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOSPITALIZATION; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; INTERLEUKIN-10; MALE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER;

EID: 85018785731     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4805-1     Document Type: Article

References (34)

1. World Health Organization (2011) Report on the burden of endemic health care-associated infection worldwide. http://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf. Accessed 16 Aug 2016
2. Conway Morris A, Anderson N, Brittan M et al (2013) Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients. Br J Anaesth 111:778–787. doi:10.1093/bja/aet205
3. Climo MW, Yokoe DS, Warren DK et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542. doi:10.1056/NEJMoa1113849
4. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A (2014) The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med 20:224–233. doi:10.1016/j.molmed.2014.01.002
5. van Vught LA, Klein Klouwenberg PMC, Spitoni C et al (2016) Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. doi:10.1001/jama.2016.2691
6. Cazalis M-A, Friggeri A, Cavé L et al (2013) Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care 17:R287. doi:10.1186/cc13150
7. Landelle C, Lepape A, Voirin N et al (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866. doi:10.1007/s00134-010-1962-x
8. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874. doi:10.1038/nri3552
9. Peronnet E, Nguyen K, Cerrato E et al (2016) Evaluation of mRNA biomarkers to identify risk of hospital acquired infections in children admitted to paediatric intensive care unit. PLoS ONE 11:e0152388. doi:10.1371/journal.pone.0152388
10. Friggeri A, Cazalis M-A, Pachot A et al (2016) Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients. Crit Care 20:204. doi:10.1186/s13054-016-1362-x
11. Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
12. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
13. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
14. Charlson ME, Sax FL (1987) The therapeutic efficacy of critical care units from two perspectives: a traditional cohort approach vs a new case-control methodology. J Chronic Dis 40:31–39
15. Suetens C, Morales I, Savey A et al (2007) European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J Hosp Infect 65(Suppl 2):171–173. doi:10.1016/S0195-6701(07)60038-3
16. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496. doi:10.2307/2670170
17. Lukaszewicz A-C, Grienay M, Resche-Rigon M et al (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746–2752. doi:10.1097/CCM.0b013e3181ab858a
18. Gomez HG, Gonzalez SM, Londoño JM et al (2014) Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*. Crit Care Med 42:771–780. doi:10.1097/CCM.0000000000000100
19. Dulhunty JM, Lipman J, Finfer S, Sepsis Study Investigators for the ANZICS Clinical Trials Group (2008) Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med 34:1654–1661. doi:10.1007/s00134-008-1160-2
20. Cheron A, Floccard B, Allaouchiche B et al (2010) Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 14:R208. doi:10.1186/cc9331
21. Venet F, Tissot S, Debard A-L et al (2007) Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 35:1910–1917. doi:10.1097/01.CCM.0000275271.77350.B6
22. Gullett JC, Nolte FS (2015) Quantitative nucleic acid amplification methods for viral infections. Clin Chem 61:72–78. doi:10.1373/clinchem.2014.223289
23. Brendish NJ, Schiff HF, Clark TW (2015) Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Infect 71:501–510. doi:10.1016/j.jinf.2015.07.008
24. Payen D, Lukaszewicz A-C, Belikova I et al (2008) Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 34:1371–1376. doi:10.1007/s00134-008-1048-1
25. Pachot A, Monneret G, Brion A et al (2005) Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33:31–38
26. Gouel-Chéron A, Allaouchiche B, Guignant C et al (2012) Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS ONE 7:e33095. doi:10.1371/journal.pone.0033095
27. Tschaikowsky K, Hedwig-Geissing M, Schiele A et al (2002) Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30:1015–1023
28. Pachot A, Monneret G, Voirin N et al (2005) Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol 114:61–69. doi:10.1016/j.clim.2004.08.015
29. Sherry RM, Cue JI, Goddard JK, et al (1996) Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 40:613-616; discussion 616-617
30. Giannoudis PV, Smith RM, Perry SL et al (2000) Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 26:1076–1081
31. Wu J, Zhou L, Liu J et al (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care Lond Engl 17:R8. doi:10.1186/cc11932
32. de Smet AMGA, Bonten MJM, Kluytmans JAJW (2012) For whom should we use selective decontamination of the digestive tract? Curr Opin Infect Dis 25:211–217. doi:10.1097/QCO.0b013e3283507f8c
33. Derde LPG, Dautzenberg MJD, Bonten MJM (2012) Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 38:931–939. doi:10.1007/s00134-012-2542-z
34. Smith RN, Nolan JP (2013) Central venous catheters. BMJ 347:f6570